Q1 2023 Holdings
Filed 2023-05-15 | 18 holdings | $133.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $14.2M | 1,629,464 | 10.6% |
| Crinetics Pharmaceuticals in(CRNX) | Common | 22663K107 | $11.9M | 741,043 | 8.9% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $11.7M | 506,818 | 8.8% |
| Horizon Therapeutics PLC | SHS | G46188101 | $10.8M | 99,217 | 8.1% |
| Biogen Inc(nsm)(BIIB) | Common | 09062X103 | $10.4M | 37,459 | 7.8% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $10.0M | 282,886 | 7.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $9.7M | 1,163,535 | 7.2% |
| Morphic Holding Inc | Common | 61775R105 | $9.3M | 246,616 | 6.9% |
| Kalvista Pharmaceuticals Inc(KALV) | Common | 483497103 | $8.8M | 1,121,982 | 6.6% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $8.3M | 77,210 | 6.2% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $8.1M | 123,165 | 6.1% |
| Iteos Therapeutics Inc(5E7) | Common | 46565G104 | $6.5M | 480,653 | 4.9% |
| Sage Therapeutics Inc(SG7) | Common | 78667J108 | $6.1M | 145,018 | 4.5% |
| Amicus Therapeutics Inc(nms)(FOLD) | Common | 03152W109 | $2.9M | 258,288 | 2.1% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $2.0M | 178,217 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | Common | 901384107 | $1.8M | 172,188 | 1.3% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $1.3M | 101,339 | 1.0% |
| Scilex Holding Co(nas)(SCLXUSD) | Common | 80880W106 | $85.2K | 10,390 | 0.1% |